Latest CSTL reports update at 2024-05-02: 2024-Q12023-Q42023-Q1
Castle Biosciences logo

Castle Biosciences CSTL

$ 24.33 6.52%

Country

usaUSA

IPO year

2019

Industry

Diagnostics research

Stock Exchange

NASDAQ GLOBALSPB

CEO

Mr. Derek Maetzold

Employees in the company

133

Shares

26.8 M

Market Cap[1]

$ 652 M

EBITDA (LTM)

$ -59.9 M

P/E (LTM)

-

P/S (LTM)

-

EPS (LTM)

-

Other stocks of industry "Diagnostics research"

References

  1. Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.